Indegene Limited — Others, 30-05-2025: Shareholders meeting

Indegene Limited sustained strong growth with revenue up 9.6% YoY to ₹28,393 million and profit after tax rising 20.8% to ₹4,067 million, driven by solid demand in Enterprise Commercial and Medical Solutions and expansion of Omnichannel Activation. Geographic footprint expanded with new centers in Hyderabad, Spain, and London, plus acquisition of UK-based MJL Communications to strengthen its European healthcare communications. The launch of Cortex, a GenAI platform for life sciences, and a partnership with Microsoft underline its AI-driven innovation. A final dividend of ₹2 per share is proposed, while Deloitte Haskins & Sells will join as new auditors, supporting governance and growth plans.